Pharma Intelligence is part of the Business Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Keep your finger on the pulse of upcoming major marked events and let Biomedtracker guide you in understanding how it impacts the market and drug development landscape as soon as it happens.
How it works
We track impactful future catalysts, analyze these commercial, clinical and regulatory activities when they happen and present them in an easily searchable interface to help you stay on top of your game. And, our analysts attend medical and investor meetings that matter to you, to bring not just the the news, but our industry-acclaimed insight to you faster.
How it can help
Biomedtracker's team of expert analysts monitors the companies, trials, deals and regulatory meetings to capture the most critical events so that you can spend more time making the right decisions for your buisness. Our Likelihood of Approval analyses are informed by these events and showcase the "bottom-line" of the news' impact on a drug's future.
Biomedtracker uniquely tracks and analyzes every event in the drug development world in real-time and sends custom email alerts based on your preferences.
Access all of the data you need to monitor the market in one place – drugs, companies, indications, targets, catalysts, endpoint data, trials, and more.
Our medical and investor conference planners and post-reports keep you abreast of developments from major meetings like JP Morgan, ASCO, and EASL.
Predict how future FDA panels may vote before the meeting happens. AdComm Insight lets subscribers see the voting history of the FDA panelists who will be adjudicating the approvability of an upcoming drug.
Your subscription to Biomedtracker includes direct access to our analyst team.
Datamonitor Healthcare, Biomedtracker
14 Jun 2017
Featuring analysts from Informa’s Biomedtracker, Datamonitor Healthcare, and Citeline, the 2017 Informa Pharma Intelligence Post-ASCO Podcast provides commentary into ASCO 2017.
Biomedtracker
26 May 2017
The 53rd annual meeting of the American Society of Clinical Oncology (ASCO) will be held in Chicago from June 2-6, 2017. This audio-only podcast features Informa Pharma Intelligence analysts Dr. Robert Jeng (Biomedtracker), Dr. David Dahan (Biomedtracker), Dr. Dominique Fontanilla (Datamonitor Healthcare), and Dr. Maria Berezina (Citeline) as they discuss notable abstracts which were released on Wednesday, May 17, 2017.
Topic Cancer
Datamonitor Healthcare, Biomedtracker
By Michael Haydock 16 May 2017
Recent and upcoming advances in chronic hepatitis B virus (HBV) treatment emerged as an important focus of the International Liver Conference (ILC) 2017.
Topic Hepatitis C
Biomedtracker, Meddevicetracker
20 Apr 2017
High impact catalysts can lead to large changes in the valuation of drugs, devices, and companies, view the infographic to see the latest evaluation
Topic Drug review Research
Biomedtracker
03 Apr 2017
Learn why pharmaceutical, biotech, and investment companies rely on BioMedTracker for its insight on the likelihood of approval, commercial potential, and future data and regulatory catalysts for drugs within the competitive landscape of every important disease and indication.
Biomedtracker
23 Mar 2017
There is no doubt that 2016 will be marked as year of surprising results. None more so than how life science companies fared in the capital markets.
Topic Business strategies
Pharmaprojects, Biomedtracker, Trialtrove
By Rachel Meighan-Mantha 22 Mar 2017
Epigenetic Drugs in Oncology: Current Clinical Landscape and Emerging Trends
Biomedtracker
28 Feb 2017
Biomedtracker's Early 2017 Outlook Infographic shows the igh Impact Catalysts that will have an effect of the future of the Pharam Industry
Topic Drug approval Drug review
Biomedtracker
By Biomedtracker 08 Feb 2017
In this report, we cover catalysts from 36 drugs, devices and diagnostics expected to occur in early 2017.
Topic Drug approval Drug review
Biomedtracker
11 Aug 2016
The 34th annual JP Morgan Healthcare Conference is being held in San Francisco, CA from January 11- 14, 2016
Biomedtracker
11 Aug 2016
The 34th annual JP Morgan Healthcare Conference is being held in San Francisco, CA from January 11- 14, 2016
Biomedtracker
11 Aug 2016
The 34th annual JP Morgan Healthcare Conference is being held in San Francisco, CA from January 11- 14, 2016
Biomedtracker
08 Aug 2016
Overview TCT was held this year from October 10-15 in San Francisco, CA. Coronary stents had the most new salient data at this year's TCT, especially first data from the ABSORB III IDE trial.
Topic immuno-oncology
Biomedtracker
By Matt Dias 27 Apr 2016
Summary The 34th annual JP Morgan Healthcare Conference was held in San Francisco, CA from January 11-14, 2016. A comprehensive list of events and catalysts that were announced or updated at the conference is included in this report. Additionally, below are some key points from the conference’s company presentations.
Patricia specializes in
+26 year(s) experience
Gail specializes in
+21 year(s) experience
Rachel specializes in
+21 year(s) experience
Datamonitor Healthcare's expert coverage of key diseases, companies, drugs and market trends makes it the go-to product for pharmaceutical and biotechnology companies to support the development and validation of their strategic plans and commercial decisions. Its accurate and objective drug sales forecasts and segmented patient based disease forecasts are continually updated in reaction to key changes in the market, ensuring decisions are always based on the current reality of the market place.
From licensing, to clinical trials, to competitor activity - you’ll stay up to date on developments in your market thanks to our global team of over 60 journalists and analysts.
Medtrack follows all the companies and people that touch Healthcare: financing, drug discovery, manufacturing, contract manufacturing and development. Coverage spans discovery through patent expiry and loss of market exclusivity and generic entry.
Looking for more products Product Finder
Request a Demo
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
How can we help you?
Our team is always happy to hear from you. Please call us at:
Report store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
